NIGMS to Fund Network of PGx, Genomics-based Drug Prediction Science Centers | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to fund a network of centers that will use pharmacogenomics and more advanced genomic approaches to develop innovative methods for predicting drug responses.

The National Institute for General Medical Sciences will provide up to $1.8 million per year to each of these research centers, which beginning in 2015 will serve as anchors for the Pharmacogenomics Research Network, a program NIH has supported since 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.